Liu X, Fang W, Lu W, Xu M, Wu Z, Su D
AAPS PharmSciTech. 2025; 26(3):67.
PMID: 39979516
DOI: 10.1208/s12249-025-03056-0.
Uttreja P, Karnik I, Youssef A, Narala N, Elkanayati R, Baisa S
Pharmaceutics. 2025; 17(1).
PMID: 39861711
PMC: 11768142.
DOI: 10.3390/pharmaceutics17010063.
Xie B, Liu Y, Li X, Yang P, He W
Acta Pharm Sin B. 2024; 14(11):4683-4716.
PMID: 39664427
PMC: 11628819.
DOI: 10.1016/j.apsb.2024.08.027.
Rehman M, Tahir N, Sohail M, Qadri M, Duarte S, Brandao P
Pharmaceutics. 2024; 16(11).
PMID: 39598500
PMC: 11597327.
DOI: 10.3390/pharmaceutics16111376.
Frent O, Stefan L, Morgovan C, Duteanu N, Dejeu I, Marian E
Int J Mol Sci. 2024; 25(22).
PMID: 39596162
PMC: 11594109.
DOI: 10.3390/ijms252212091.
Self-Nanoemulsifying Drug Delivery System of Morin: A New Approach for Combating Acute Alcohol Intoxication.
Mao J, Liu X, Zhang L, Chen Y, Zhou S, Liu Y
Int J Nanomedicine. 2024; 19:10569-10588.
PMID: 39439503
PMC: 11495198.
DOI: 10.2147/IJN.S472287.
Spatiotemporal delivery of multiple components of rhubarb-astragalus formula for the sysnergistic treatment of renal fibrosis.
Zhang Q, Ye X, Zhu L, Xu Z, Hou Y, Ke Q
Front Pharmacol. 2024; 15:1456721.
PMID: 39415839
PMC: 11480027.
DOI: 10.3389/fphar.2024.1456721.
A Comprehensive Review of Challenges in Oral Drug Delivery Systems and Recent Advancements in Innovative Design Strategies.
Loke Y, Jayakrishnan A, Mod Razif M, Yee K, Kee P, Goh B
Curr Pharm Des. 2024; 31(5):360-376.
PMID: 39390835
DOI: 10.2174/0113816128338560240923073357.
Self-nanoemulsifying drug delivery system for nebulization: fabrication and evaluation for systemic delivery of atorvastatin.
Saeed M, Shah K, Fahad M, Shah S, Badshah S, Shah H
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39361170
DOI: 10.1007/s00210-024-03494-w.
"Enhancing Oral Drug Absorption: Overcoming Physiological and Pharmaceutical Barriers for Improved Bioavailability".
Maurya R, Vikal A, Patel P, Narang R, Kurmi B
AAPS PharmSciTech. 2024; 25(7):228.
PMID: 39354282
DOI: 10.1208/s12249-024-02940-5.
The Cytoprotective Effect of C60 Derivatives in the Self-Microemulsifying Drug Delivery System against Triptolide-Induced Cytotoxicity In Vitro.
Xu B, Wang Z, Zhang H, Xu X, Tang M, Wang G
Molecules. 2024; 29(17).
PMID: 39274920
PMC: 11396586.
DOI: 10.3390/molecules29174073.
Natural Food Components as Biocompatible Carriers: A Novel Approach to Glioblastoma Drug Delivery.
Tharamelveliyil Rajendran A, Vadakkepushpakath A
Foods. 2024; 13(17).
PMID: 39272576
PMC: 11394703.
DOI: 10.3390/foods13172812.
Development and optimization of a self micro-emulsifying drug delivery system (SMEDDS) for co-administration of sorafenib and curcumin.
Huang X, Feng L, Lu X, Yang F, Liu S, Wei X
Drug Deliv Transl Res. 2024; .
PMID: 39207633
DOI: 10.1007/s13346-024-01699-3.
Exploring novel type of lipid-bases drug delivery systems that contain one lipid and one water-soluble surfactant only.
Dong X, Thao Duyen Nguyen N
Int J Pharm. 2024; 661:124447.
PMID: 39002820
PMC: 11571485.
DOI: 10.1016/j.ijpharm.2024.124447.
Suspensions of antibiotics in self-emulsifying oils as a novel approach to formulate eye drops with substances which undergo hydrolysis in aqueous environment.
Krzeminska K, Sznitowska M, Wroblewska M, Wolska E, Winnicka K
Drug Deliv. 2024; 31(1):2372279.
PMID: 38992340
PMC: 11249160.
DOI: 10.1080/10717544.2024.2372279.
Enhancing the oral bioavailability of fisetin: polysaccharide-based self nano-emulsifying spheroids for colon-targeted delivery.
Gunjal P, Vishwas S, Kumar R, Bashir B, Kumar B, Khurana N
Drug Deliv Transl Res. 2024; 14(10):1-17.
PMID: 38789909
DOI: 10.1007/s13346-024-01634-6.
Self Emulsifying Delivery System of Cissus quadrangularis: Evidence of Enhanced Efficacy and Promising Pharmacokinetic Profile in the Management of Osteoporosis.
Garg J, Ghoshal G, Sharma G, Katare O, Bhadada S
AAPS PharmSciTech. 2024; 25(5):107.
PMID: 38730121
DOI: 10.1208/s12249-024-02821-x.
Combination of the Topical Photodynamic Therapy of Chloroaluminum Phthalocyanine Liposomes with Fexinidazole Oral Self-Emulsifying System as a New Strategy for Cutaneous Leishmaniasis Treatment.
Silva R, Damasio D, Coelho L, Morais-Teixeira E, Queiroz-Junior C, Souza P
Pharmaceutics. 2024; 16(4).
PMID: 38675171
PMC: 11054953.
DOI: 10.3390/pharmaceutics16040509.
Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and Assessment.
Mujtaba M, Kaleem M, Chaware R, Ingole A, Asiri Y, Hassan M
ACS Omega. 2024; 9(14):16346-16357.
PMID: 38617636
PMC: 11007800.
DOI: 10.1021/acsomega.3c10506.
Effects of excipients on the interactions of self-emulsifying drug delivery systems with human blood plasma and plasma membranes.
Le-Vinh B, Le N, Phan T, Lam H, Bernkop-Schnurch A
Drug Deliv Transl Res. 2024; 14(11):3200-3211.
PMID: 38411893
PMC: 11445307.
DOI: 10.1007/s13346-024-01541-w.